MarketPulse
C

$COLL

3 articles found
3 positive
0 negative
0 neutral
The Motley FoolThe Motley Fool··Seena Hassouna

Collegium's ADHD Pivot Accelerates as General Counsel Trims Stakes

Collegium's General Counsel sells modest stake as company bets $650M acquiring AZSTARYS to accelerate ADHD strategy shift, with Jornay PM showing 48% growth.
COLLrevenue growthinsider sale
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Collegium to Showcase Real-World Pain Drug Data at 2026 Medical Conference

Collegium Pharmaceutical to present real-world clinical data on pain medication BELBUCA at major medical conference in March 2026.
COLLclinical evidenceCollegium Pharmaceutical
GlobeNewswire Inc.GlobeNewswire Inc.··Collegium Pharmaceutical, Inc.

Paris Hilton Partners with Collegium to Destigmatize ADHD Treatment

Collegium Pharmaceutical partners with Paris Hilton to launch 'Embrace Your Sparkle' campaign promoting ADHD awareness and JORNAY PM treatment.
COLLmental healthADHD awareness